Oscillo Flu Relief Settlement Preliminary Approval: Here’s What To Do

May 26th, 2012. By AbiK

Remember this one? The Oscillo Flu Relief false advertising class action? Or, for those of you who can pronounce it, the Oscillococcinum class action lawsuit…which basically alleged that a couple of homeopathic ingredients and sugar may not actually do a blessed thing (expect perhaps a placebo effect) on curing or diminishing your flu symptoms.

Well, the class action lawsuit was actually against Boiron and it covered more than Oscillo. Now, it’s got a preliminary approval on its settlement. So here we go with the settlement details…

Am I part of the Oscillo Flu Relief Class Action Settlement?

You are if you purchased Oscillococcinum, Children’s Oscillococcinum, Arnicare, Quietude, Camilia, Coldcalm and ‘other products manufactured by Boiron’ between Jan. 1, 2000 and the present. You’re NOT a part of the class for this settlement if you were a California resident whose only purchase of a Boiron product was of Children’s Coldcalm in California after August 31, 2006.

What do I get as part of the Oscillo Flu Relief Class Action Settlement?

As with all class action settlements, the amount each class member receives will be contingent on how many claimants (ie, class members) submit a claim form. However, class members who file timely and valid claims (see below) are eligible to receive up to $100.00 per household.

For this settlement, a settlement fund of $5 million is being set up to pay claims to eligible Class Members, attorneys’ fees and costs, and the notice and claims administration costs. Boiron (the company that makes Oscillo) is also agreeing to make certain changes to the manner in which it advertises the products involved in the class action lawsuit.

What do I have to do now?

Here are your options to…

Submit a Claim: Do not submit a claim here at LawyersandSettlements.com. You can submit your Oscillo claim form at the claims administrator’s website here: http://www.gilardi.com/boironsettlement/FileClaim.

Otherwise, you will need to send in a completed claim form and, if available, proof of purchase of the applicable Boiron products you’ve purchased to the Claims Administrator (address shown below). Your claim must be postmarked no later than 45 days after the date the Court enters the Judgment.

The Court will hold a hearing on August 13, 2012 at 2:30 p.m. at the federal courthouse at 940 Front Street, Courtroom 11, San Diego, CA 92101, to consider final approval of the Boiron settlement, including payment of reasonable attorneys’ fees and costs to Class Counsel related to obtaining the settlement relief, an incentive award to each of the named Plaintiffs, and related issues.

Object to the Settlement: If you want to object to the Oscillo settlement you have to file a written statement with the Court and serve a copy on Class Counsel, Counsel for Defendants and the Claims Administrator, postmarked by July 14, 2012. Instructions for how to object are explained in the detailed notice at www.gilardi.com/boironsettlement.

Exclude yourself from the Settlement: If you do not want to be bound by the settlement, you must send a letter to the Claims Administrator at the address below requesting to be excluded. The letter must be postmarked by July 14, 2012. If you exclude yourself, you cannot receive a benefit from this settlement, but you can sue the manufacturer of the Products for the claims alleged in this lawsuit. If you do not exclude yourself from the settlement or do nothing, you will be bound by the Court’s decisions.

For more information and to obtain a detailed notice, claim form, list of Products, or other documents, visit www.gilardi.com/boironsettlement or call, toll-free, 877-256-3879, or write to Boiron Claims Administrator, P.O. Box 8060, San Rafael, CA 94912-8060.

Tags: Boiron, Class Action Lawsuit, Consumer Fraud, false advertising, Homeopathic remedy, Oscillo Flu Relief Settlement

This was posted on Saturday, May 26th, 2012 at 9:32 am and is filed under Class Action, Consumer Fraud, Drugs/Medical, Emerging Issues, Settlement . Feel free to respond, or trackback. Read our comments policy.